Benzoimidazol-2-yl pyrimidines and pyrazines as modulators of the histamine H4 receptor

Benzoimidazol-2-yl pyrimidines and pyrazines, pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by H4 receptor activity, including allergy, asthma, autoimmune diseases, and pruritis.

Saved in:
Bibliographic Details
Main Authors EDWARDS JAMES P, VENABLE JENNIFER D, PIPPEL DANIEL J, KINDRACHUK DAVID E, MAPES CHRISTOPHER M
Format Patent
LanguageEnglish
Published 06.02.2014
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online AccessGet full text

Cover

More Information
Summary:Benzoimidazol-2-yl pyrimidines and pyrazines, pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by H4 receptor activity, including allergy, asthma, autoimmune diseases, and pruritis.
Bibliography:Application Number: US201314051962